177 related articles for article (PubMed ID: 14676211)
1. Catalytic activity of human ADAM33.
Zou J; Zhu F; Liu J; Wang W; Zhang R; Garlisi CG; Liu YH; Wang S; Shah H; Wan Y; Umland SP
J Biol Chem; 2004 Mar; 279(11):9818-30. PubMed ID: 14676211
[TBL] [Abstract][Full Text] [Related]
2. ADAM33 enzyme properties and substrate specificity.
Zou J; Zhang R; Zhu F; Liu J; Madison V; Umland SP
Biochemistry; 2005 Mar; 44(11):4247-56. PubMed ID: 15766253
[TBL] [Abstract][Full Text] [Related]
3. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
4. Human ADAM33: protein maturation and localization.
Garlisi CG; Zou J; Devito KE; Tian F; Zhu FX; Liu J; Shah H; Wan Y; Motasim Billah M; Egan RW; Umland SP
Biochem Biophys Res Commun; 2003 Jan; 301(1):35-43. PubMed ID: 12535637
[TBL] [Abstract][Full Text] [Related]
5. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
[TBL] [Abstract][Full Text] [Related]
6. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.
Lammich S; Kojro E; Postina R; Gilbert S; Pfeiffer R; Jasionowski M; Haass C; Fahrenholz F
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3922-7. PubMed ID: 10097139
[TBL] [Abstract][Full Text] [Related]
7. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.
Roghani M; Becherer JD; Moss ML; Atherton RE; Erdjument-Bromage H; Arribas J; Blackburn RK; Weskamp G; Tempst P; Blobel CP
J Biol Chem; 1999 Feb; 274(6):3531-40. PubMed ID: 9920899
[TBL] [Abstract][Full Text] [Related]
8. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
9. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
Roy R; Wewer UM; Zurakowski D; Pories SE; Moses MA
J Biol Chem; 2004 Dec; 279(49):51323-30. PubMed ID: 15381692
[TBL] [Abstract][Full Text] [Related]
10. Catalytic properties of ADAM19.
Chesneau V; Becherer JD; Zheng Y; Erdjument-Bromage H; Tempst P; Blobel CP
J Biol Chem; 2003 Jun; 278(25):22331-40. PubMed ID: 12682046
[TBL] [Abstract][Full Text] [Related]
11. Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity.
Kang T; Park HI; Suh Y; Zhao YG; Tschesche H; Sang QX
J Biol Chem; 2002 Dec; 277(50):48514-22. PubMed ID: 12393862
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the catalytic domain of human ADAM33.
Orth P; Reichert P; Wang W; Prosise WW; Yarosh-Tomaine T; Hammond G; Ingram RN; Xiao L; Mirza UA; Zou J; Strickland C; Taremi SS; Le HV; Madison V
J Mol Biol; 2004 Jan; 335(1):129-37. PubMed ID: 14659745
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin.
Hiraoka Y; Ohno M; Yoshida K; Okawa K; Tomimoto H; Kita T; Nishi E
J Neurochem; 2007 Sep; 102(5):1595-1605. PubMed ID: 17555553
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.
Cruz AC; Frank BT; Edwards ST; Dazin PF; Peschon JJ; Fang KC
J Biol Chem; 2004 Feb; 279(7):5612-20. PubMed ID: 14625290
[TBL] [Abstract][Full Text] [Related]
15. Identification of the catalytic residues of alpha-amino acid ester hydrolase from Acetobacter turbidans by labeling and site-directed mutagenesis.
Polderman-Tijmes JJ; Jekel PA; Jeronimus-Stratingh CM; Bruins AP; Van Der Laan JM; Sonke T; Janssen DB
J Biol Chem; 2002 Aug; 277(32):28474-82. PubMed ID: 12011065
[TBL] [Abstract][Full Text] [Related]
16. Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.
Higashi S; Miyazaki K
J Biol Chem; 2003 Apr; 278(16):14020-8. PubMed ID: 12586836
[TBL] [Abstract][Full Text] [Related]
17. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
18. Protease domain of human ADAM33 produced by Drosophila S2 cells.
Prosise WW; Yarosh-Tomaine T; Lozewski Z; Ingram RN; Zou J; Liu JJ; Zhu F; Taremi SS; Le HV; Wang W
Protein Expr Purif; 2004 Dec; 38(2):292-301. PubMed ID: 15555945
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.
Endres K; Anders A; Kojro E; Gilbert S; Fahrenholz F; Postina R
Eur J Biochem; 2003 Jun; 270(11):2386-93. PubMed ID: 12755693
[TBL] [Abstract][Full Text] [Related]
20. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
